Immunohistochemical study of MT-MMP tissue status in gastric carcinoma and correlation with survival analyzed by univariate and multivariate analysis

Oncology Reports

Volumn 5, Issue 6, 1998, Pages 1483-1488

  Bando, Etsuro ^a   Yonemura, Yutaka ^a   Endou, Yoshio ^a   Sasaki, Takuma ^a   Taniguchi, Keizou ^a   Fujita, Hideto ^a   Fushida, Sachio ^a   Fujimura, Takashi ^a   Nishimura, Gen Ichi ^a   Miwa, Koichi ^a   Seiki, Motoharu ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Gastric cancer; Immunohistochemistry; MT MMT; Prognostic factor

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; GELATINASE A; MATRIX METALLOPROTEINASE; UFT;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER SURVIVAL; CELL MEMBRANE; CONTROLLED STUDY; FIBROBLAST; GASTRECTOMY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTHERMIC THERAPY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; STOMACH CARCINOMA;

EID: 13144275193     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.6.1483     Document Type: Article

References (24)

1. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki-M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65, 1994.
2. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6: 121-125, 1990.
3. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991.
4. Matrisian LM: The matrix-degrading metalloproteinases. BioEssays 14: 455-463, 1992.
5. Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J and Seiki M: Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells, Oncogene 7: 77-83, 1992.
6. Tsuchiya Y, Sato H, Endo Y, Okada Y, Mai M, Sasaki T and Seiki M: Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo. Cancer Res 53: 1397-1402, 1993.
7. Tsuchiya Y, Endo Y, Sato H, Okada Y, Mai M, Sasaki T and Seiki M: Expression of type-IV collagenases in human tumor cell lines that can form liver colonies in chick embryos. Int J Cancer 56: 46-51, 1994.
8. Stetler-Stevenson WG, Anavoorian S and Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541-573, 1993.
9. Pyke C, Ralfkiaer E, Huhtala P, Hurskainen T, Dano K and Tryggvason K: Localization of messenger RNA for 72-kDa and 92-kDa-type-IV collagenases in human skin cancers by in situ hybridization. Cancer Res 52: 1336-1341, 1992.
10. Poulsom R, Pignatelli M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffery RE, et al: Stromal expression of 72-kDa type-IV-collagenase (MMP-2) and TIMP-2 nRNAs in colorectal neoplasia. Am J Pathol 141: 389-396, 1992.
11. Nomura H, Sato H, Setki M, Mai M and Okada Y: Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 55: 3263-3266, 1995.
12. Japanese Research Society for Gastric Cancer: Japanese classification of gastric carcinoma first English edition. Kanehara & Co. Ltd, Tokyo.
13. Yonemura Y, Fujimura T, Fushida S, Takegawa S, Kamata T, Katayama K, et al: Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 15: 530-536, 1991.
14. Yonemura Y, Sawa T, Kinoshita K, Matsuki N, Fushida S, Tanaka S, et al: Neoadjuvant chemotherapy for high-grade advanced gastric cancer. World J Surg 17: 256-262, 1993.
15. Sato Y, Mukai K, Watanabe S, Goto M and Shimosato Y: AMex method. Am J Pathol 125: 431-435, 1986.
16. Kalbfleisch JD and Prentice RL: The statistical analysis of failure time data. John Wiley&Sons Inc., New York, 1980.
17. Cox DR: Regression models and life tables. JR Stat Soc B 34: 187-220, 1972.
18. Yonemura Y, Ninomiya I, Nojima N, Sugiyama K, Fujimura T, Tsuchihara K, et al: Prognostic value of urokinase-type plasminogen activators in gastric cancer. Oncol Rep 1: 765-772. 1994.
19. Levy AT, Cioce V, Sobel ME, Garbisa S, Grigioni WF, Liotta LA, et al: Increased expression of the Mr-72,000 type-IV collagenase in human colonic adenocarcinoma. Cancer Res 51: 434-444, 1991.
20. Ohtani H, Motohashi H, Sato H, Seiki M and Nagura H: Dual over-expression pattern of membrane-type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy. Int J Cancer 68: 565-570, 1996.
21. Polette M, Nawrocki B, Gilles C, Sato H, Seiki M, Tournier JM and Birembaut P: MT-MMP expression and localisation in human lung and breast cancers. Virchows Arch 428: 29-35, 1996.
22. Tokuraku M, Sato H, Murakami S, Okada Y, Watanabe Y and Seiki M: Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 64: 355-359, 1995.
23. Kaji M, Yonemura Y, Harada S, Liu X, Terada I and Yamamoto H: Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation of invasiveness of gastric cancer cells. Cancer Gene Ther 6: 393-404, 1996.
24. Hirono Y, Fushida S, Yonemura Y, Yamamoto H, Watanabe H and Raz A: Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer. Br J Cancer 74: 2003-2007, 1996.